13.70
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Syndax Pharmaceuticals (SNDX) Q3 Earnings Preview: Key Expectati - GuruFocus
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
Is Syndax Pharmaceuticals Inc. stock reversal real or fake2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
How risky is Syndax Pharmaceuticals Inc. stock nowJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Applying Wyckoff theory to Syndax Pharmaceuticals Inc. stockTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicalsJuly 2025 Outlook & Scalable Portfolio Growth Methods - newser.com
Is Syndax Pharmaceuticals Inc. stock poised for growthJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
Y Intercept Hong Kong Ltd Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
B. Riley Issues Optimistic Estimate for SNDX Earnings - MarketBeat
Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Previe - GuruFocus
Is it too late to sell Syndax Pharmaceuticals Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com
Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure - Markets Mojo
Detecting support and resistance levels for Syndax Pharmaceuticals Inc.Earnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors - TipRanks
Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com
Why Syndax Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Is Syndax Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-10-30 09:56:20 - newser.com
Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib - MSN
Syndax Announces Participation in November Investor Conferences - The Manila Times
Is Syndax Pharmaceuticals Inc. (1T3) stock a buy during volatile marketsEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Syndax (Nasdaq: SNDX) to join fireside chats at UBS, Guggenheim, Stifel, Jefferies - Stock Titan
Syndax Pharmaceuticals (SNDX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Is Syndax Pharmaceuticals Inc. stock a safe investment in uncertain marketsDividend Hike & AI Driven Stock Price Forecasts - newser.com
Leading vs lagging indicators on Syndax Pharmaceuticals Inc. performanceTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
Will Syndax Pharmaceuticals Inc. stock maintain momentum in 20252025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
How Syndax Pharmaceuticals Inc. stock performs in stagflationTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-27 23:41:18 - newser.com
Is Syndax Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 Chart Watch & Fast Gaining Stock Reports - Fundação Cultural do Pará
Will Syndax Pharmaceuticals Inc. stock benefit from sector rotation2025 Top Gainers & Precise Buy Zone Identification - Fundação Cultural do Pará
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):